An2 Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in An2 Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including An2 Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in An2 Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $482k | 224k | 2.15 |
| 2024-03-31 | $92k | 28k | 3.25 |
| 2023-12-31 | $288k | 14k | 20.49 |
| 2023-06-30 | $332k | 39k | 8.50 |
| 2022-03-31 | $294k | 20k | 15.08 |